Audentes Therapeutics Prices IPO
San Francisco-based Audentes Therapeutics has priced its IPO, saying late Tuesday evening that it will offer 5,000,000 shares of its common stock at $15.00 per share. The company priced at the midpoint of its earlier, estimate IPO range of $14.00 to $16.00 per share. The company will begin trading this morning on the NASDAQ Global Market AS BOLD. The company was venture backed Deerfield Management, Sofinnova Ventures, Venrock,OrbiMed, 5AM Ventures, and Versant Ventures.
posted on Wednesday, July 20, 2016
Related companies:
Audentes Therapeutics
Related stories:
> Audentes Therapeutics Sets IPO Pricing Range
> Audentes Therapeutics Gets $42.5M For Rare Diseases
> Eidos Therapeutics Prices IPO, To Debut Today
> Merck Buys Sirna Therapeutics
> Iconic Therapeutics Finds $20M
silicontap.com Home